Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types

BACKGROUND: PD(L)1 antibodies (anti‐PD(L)‐1) have been a major breakthrough in several types of cancer. Novel patterns of response and progression have been described with anti‐PD(L)‐1. We aimed at characterizing pseudoprogression (PSPD) among patients with various solid tumor types treated by anti‐...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Med
Main Authors: Martin‐Romano, Patricia, Castanon, Eduardo, Ammari, Samy, Champiat, Stéphane, Hollebecque, Antoine, Postel‐Vinay, Sophie, Baldini, Capucine, Varga, Andrea, Michot, Jean Marie, Vuagnat, Perrine, Marabelle, Aurélien, Soria, Jean‐Charles, Ferté, Charles, Massard, Christophe
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2020
Fag:
Clinical Cancer Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7163099/
https://ncbi.nlm.nih.gov/pubmed/32074405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2797
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker